Biography:

 

Dr. Gillian Hanley is an Associate Professor in the Department of Obstetrics & Gynaecology at the University of British Columbia. She is a Canada Research Chair in Population-Based Gynecologic and Perinatal Outcomes and an internationally recognized leader in women’s health research and ovarian cancer prevention. She is also the current Executive Director of the Women’s Health Research Institute.

Dr. Hanley’s research program uses population-based data, epidemiology, health services research, and health economics to improve health outcomes for women and gender-diverse people across the life course. Her work spans ovarian cancer prevention and survivorship, reproductive and perinatal health, women’s mental health, and child health outcomes, with a focus on generating evidence that informs clinical practice, policy, and health system decision-making.

She is internationally recognized for her research advancing opportunistic salpingectomy as a safe and effective ovarian cancer prevention strategy. Her work has contributed to clinical practice guidelines and policy recommendations adopted nationally and internationally and has helped shape a global shift toward prevention-focused gynecologic care. She collaborates closely with clinicians, policymakers, and health system leaders to support the implementation of evidence-based prevention strategies. In addition to her work in gynecologic oncology, Dr. Hanley leads research examining the impact of pharmacologic and other treatments for mental health conditions during pregnancy and the postpartum period on maternal and child outcomes.

Dr. Hanley is committed to strengthening interdisciplinary research and advancing collaborative, inclusive, and impactful research that improves the health of women, girls, and gender-diverse people in British Columbia, across Canada, and globally.